Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BLM | P54132 | 1/20 | 0.52 |
| ▸ | LMNA | P02545 | 1/20 | 0.50 |
| ▸ | PTPN1 | P18031 | 3/20 | 0.39 |
| ▸ | ALOX15 | P16050 | 3/20 | 0.37 |
| ▸ | MEN1 | O00255 | 1/20 | 0.37 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.37 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.37 |
| ▸ | CA1 | P00915 | 2/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.33 |
| ▸ | PTPN2 | P17706 | 1/20 | 0.32 |
| ▸ | CDC25B | P30305 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8589919 | 1.00 | BLM (0.52) | BLMLMNAPTPN1ALOX15MEN1 | |
| SCHEMBL2788144 | 0.98 | BLM (0.55) | BLMLMNAPTPN1ALOX15MEN1 | |
| SCHEMBL3577262 | 0.98 | BLM (0.55) | BLMLMNAPTPN1ALOX15MEN1 | |
| SCHEMBL11481735 | 0.82 | ALDH1A1 (0.46) | BLMPTPN1CA1ALDH1A1 | |
| SCHEMBL9176733 | 0.82 | ALDH1A1 (0.46) | CA1ALDH1A1 | |
| SCHEMBL1410690 | 0.82 | ALDH1A1 (0.46) | CA1ALDH1A1 | |
| SCHEMBL6271680 | 0.81 | BLM (0.56) | BLMLMNAPTPN1ALOX15MEN1 | |
| SCHEMBL26109378 | 0.81 | BLM (0.56) | BLMLMNAPTPN1ALOX15MEN1 | |
| SCHEMBL1410439 | 0.80 | ACE2 (0.52) | CA1ALDH1A1 | |
| SCHEMBL16666684 | 0.80 | BLM (0.55) | BLMLMNAPTPN1ALOX15MEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4687854-A2 | LIPIDS AND LIPID-LIKE COMPOUNDS FOR THERAPEUTIC LIPID NANOPARTICLE (LNP) DELIVERY | Flagship Labs 114, Inc. (US) | 2026-02-11 | — | — | EP | disclosed |
| WO-2024211865-A2 | LIPIDS AND LIPID-LIKE COMPOUNDS FOR THERAPEUTIC LIPID NANOPARTICLE (LNP) DELIVERY | OMEGA THERAPEUTICS, INC. (US) | 2024-10-10 | — | — | WO | disclosed |
| US-7462427-B2 | Liquid crystal compounds with branched or cyclic end groups | QINETIQ LIMITED (GB) | 2008-12-09 | — | — | US | disclosed |
| EP-0994093-B1 | POLYHYDROXYPHENOL DERIVATIVES AND PREVENTIVE AND THERAPEUTIC AGENTS FOR BONE AND CARTILAGE DISEASES CONTAINING THE SAME | HOECHST MARION ROUSSEL LTD (JP) | 2005-12-28 | — | — | EP | disclosed |
| US-20040206933-A1 | Liquid crystal compounds with branched or cyclic end groups | QINETIQ LIMITED (GB) | 2004-10-21 | — | — | US | disclosed |
| WO-2003024903-A1 | LIQUID CRYSTAL COMPOUNDS WITH BRANCHED OR CYCLIC END GROUPS | QINETIQ LIMITED (GB) | 2003-03-27 | — | — | WO | disclosed |
| US-6177474-B1 | AROMATIC COMPOUND CONTAINING KETONE AND HYDROXY GROUPS | HOECHST MARION ROUSSEL (FR) | 2001-01-23 | — | — | US | disclosed |
| EP-0994093-A1 | POLYHYDROXYPHENOL DERIVATIVES AND PREVENTIVE AND THERAPEUTIC AGENTS FOR BONE AND CARTILAGE DISEASES CONTAINING THE SAME | Hoechst Marion Roussel, Ltd. (JP) | 2000-04-19 | — | — | EP | disclosed |
| US-4942249-A | Process for producing vitamin E | HOFFMANN-LA ROCHE INC. (US) | 1990-07-17 | — | — | US | disclosed |
| US-4877890-A | Vitamin E intermediate | HOFFMANN-LA ROCHE INC. (US) | 1989-10-31 | — | — | US | disclosed |
| EP-0317607-A1 | A NOVEL PROCESS FOR PRODUCING ALPHA-TOCOPHEROL AND NOVEL INTERMEDIATES IN THIS PROCESS. | HOFFMANN LA ROCHE (CH) | 1989-05-31 | — | — | EP | disclosed |
| US-4801724-A | Vitamin E intermediate | HOFFMANN-LA ROCHE INC. (US) | 1989-01-31 | — | — | US | disclosed |
| WO-1988009791-A1 | A NOVEL PROCESS FOR PRODUCING ALPHA-TOCOPHEROL AND NOVEL INTERMEDIATES IN THIS PROCESS | F. HOFFMANN-LA ROCHE & CO. AKTIENGESELLSCHAFT (CH) | 1988-12-15 | — | — | WO | disclosed |